Toripalimab with chemoradiotherapy followed by toripalimab maintenance therapy for newly diagnosed, high-risk, locally advanced cervical cancer (TorCH-CC): A single-arm phase II study.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Shuangzheng Jia, Rui Wang, Xuejiao Yang, Jusheng An
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410812700
